Ocugen has reported preliminary phase 2 data on its eye disease gene therapy, providing more evidence that the candidate may ...

Designation underscores the potential of this chemically induced, off-the-shelf cell therapy to address a high unmet need in ...

Regene Therapeutics Co., Ltd. ("iRegene" or the "Company"), a biotechnology company pioneering chemically induced allogeneic cell therapy, today announced that its lead product, NouvNeu001, has been ...

NouvNeu004: Recently received I-III all-stage IND approval from the NMPA, making it the world's first cell therapy product for Multiple System Atrophy (MSA) and iRegene's third self-developed product ...

Saltillo, a global leader in augmentative and alternative communication (AAC), is pleased to announce the acquisition of the ...

Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...

Founders waste months with coaches who can't solve their real problems. The issue isn't effort, it's training mismatch.

Stoke Therapeutics advances TANGO ASO for Dravet, with Zorevunersen Phase 3 data showing seizure reduction and a delayed 2027 ...

Compass Therapeutics, Inc. is rated a Buy with strong cash position and strong data readout by the end of 1H 2026. Read more ...

Kansas City Chiefs quarterback Patrick Mahomes on Thursday spoke publicly for the first time since tearing knee ligaments in ...

The number of active commercial cancer centers which are eligible to order and use RenovoCath has increased from five in September 2025 to nine currently and growing with the addition of City of Hope ...

Prosecutors in New Mexico are holding court over the Timothy Busfield child sex abuse case ... and say they can prove beyond ...